Anne-Karen Hunt joined Demant in November as President of the Diagnostics business areas and member of the Executive Leadership Team. She took over the position previously held by the CFO of the company, René Schneider, as interim President since April 2023.  
 
Before joining Demant, Anne-Karen Hunt has spent the last 20 years of her career in various international medical technology companies, most recently in GE HealthCare where she held the position as General Manager and President of the Ultrasound International business of the EMEA, APAC and LATAM regions.  
 
Demant President and CEO Søren Nielsen is pleased to welcome the new President of Diagnostics: 
 
“Anne-Karen Hunt is a strong profile and a strategic thinker, who has successfully led large, international organisations with a proven track record of business development and performance. She has a collaborative leadership mindset and focuses on creating trust in high-performing teams. She is the right profile for leading our Diagnostics business area into the future, and I am sure she will do great things in collaboration with the many talented people in our Diagnostics business and across Demant,” says Søren Nielsen, President and CEO in Demant.  
 
Anne-Karen Hunt is pleased to join a company with a strong purpose to change the lives of people living with hearing loss: 
 
“I am excited to join Demant. The combination of a company truly committed to hearing healthcare, a strong purpose of making life-changing differences and a long track record of profitable growth is very interesting to me. During my career, I have always been focused on understanding the customer needs as the foundation for building business strategy, and I look forward to getting to know the Diagnostics business further and contributing to its ongoing development and success,” says Anne-Karen Hunt, President of Diagnostics, Demant.